Abemaciclib

Common Brands Actos
Drug Class
Thiazolidinedione
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Hope Chang, PharmD, AAHIVP
Hope Chang, PharmD, AAHIVP
Read More
Medically reviewed by Hope Chang, PharmD, AAHIVP last update on 20/12/2023

Overview

Abemaciclib, a targeted cancer medication, is primarily used in treating certain breast cancers. Classified as a CDK4/6 inhibitor, it specifically disrupts cancer cell growth, reducing the impact on healthy cells. Its main application is in hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, often in conjunction with hormonal therapies.

Abemaciclib’s precise targeting mechanism offers a more focused approach compared to traditional chemotherapy, making it a significant advancement in oncological treatments. This drug represents a key development in personalized cancer therapy, highlighting the shift towards more tailored and effective cancer treatment strategies.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy